Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

Speke AI to Showcase Ambient AI Solutions at UCA’s 2026 Urgent Care Convention

Speke AI is set to showcase its advanced ambient clinical intelligence solutions at the 2026 Urgent Care Convention in Chicago, highlighting its commitment to enhancing operational efficiency in urgent care settings. The company will exhibit at booth #1018, where attendees can explore Speke Express and Speke Pro, two AI-driven tools designed to streamline workflows and improve patient interactions amid rising demand and workforce challenges.

The significance of these innovations lies in their potential to transform urgent care delivery. Speke Express facilitates real-time documentation, allowing providers to maintain focus on patient care while automating administrative tasks. This capability is crucial as urgent care centers grapple with increasing patient volumes and operational complexities. Meanwhile, Speke Pro enhances this functionality by incorporating live feedback from clinical support specialists, providing a tailored experience that supports healthcare providers throughout the patient encounter. By integrating seamlessly into existing workflows, these solutions promise to elevate care quality while reducing administrative burdens.

The implications for the field are substantial, as Speke AI’s technology could shift current paradigms in urgent care operations. By enabling more efficient patient interactions and reducing documentation strain, these tools may accelerate the adoption of AI in clinical settings, potentially influencing drug development timelines and therapeutic approaches. The focus on automation and efficiency aligns with broader trends in healthcare, emphasizing the need for innovative solutions to meet the demands of modern patient care.

Source: globenewswire.com